XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.61

-4.3%

Jan 28 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Chris Boylan who wrote (9001)	3/8/1999 7:29:00 PM
From: xomadog2	Read Replies (3) of 17367

I believe that you are missing the point.The primary endpoint of this trial is mortality,not morbidity. Unless we agree on this fact there is no point in continuing the discussion we seem to be having. Yes, morbidity is a secondary endpoint.....and on that score I believe XOMA needs to have events other than mortality...morbid events...death is a morbid event but that is the primary endpoint.....multiplicity of morbid events (non death) are being measured for secondary endpoints. I hope this has enlarge the scope of your understanding of my point of view and that you are more in agreement with what I have said from reading this post.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next